Myasthenia Gravis
Conditions
Interventions
Sponsors
Neurology, Saitama medical center, Saitama medical university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The myasthenia gravis patient
Exclusion criteria
Exclusion criteria: The patient who refused this reseach
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The MG-ADL score, the ratio of each lymphocyte subset, autoantibody titer, various blood cytokine at the time of the drawing blood | — |
Countries
Japan
Outcome results
None listed